Dalia Iskander

机构：University College London

发表论文 12 篇 · 总被引 63 次 · h-index 4

代表论文

• Bivalent prefusion F vaccination in pregnancy and respiratory syncytial virus hospitalisation in infants in the UK: results of a multicentre, test-negative, case-control study (2025 · The Lancet Child & Adolescent Health · 被引 39)
• Maternal views on RSV vaccination during the first season of implementation in England and Scotland (2025 · The Lancet Infectious Diseases · 被引 11)
• Bivalent Prefusion F Vaccination in Pregnancy and Respiratory Syncytial Virus Hospitalisation in Infants: Results of a Prospective, Multi-Centre, Test-Negative Study (2025 · SSRN Electronic Journal · 被引 5)
• Update to: Study Pre-protocol for “BronchStart - The Impact of the COVID-19 Pandemic on the Timing, Age and Severity of Respiratory Syncytial Virus (RSV) Emergency Presentations; a Multi-Centre Prospective Observational Cohort Study” (2024 · Wellcome Open Research · 被引 4)
• BronchStop Study Protocol, Season 2 (2025 · NIHR Open Research · 被引 2)
• A national programme of bivalent prefusion F vaccination in pregnancy and protection against respiratory syncytial virus hospitalisation in infants until age 6 months in the UK: a multicentre, prospective, test-negative, case–control study (2026 · The Lancet Child & Adolescent Health · 被引 1)